,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,16467,3,3,,103217374,56208,Unspecified,,,,,Calculated partition coefficient (clogP),Other,7636859.0,
1,19420,3,4,,103217374,56208,Unspecified,,,,,Partition coefficient (logD7.4),Other,7636859.0,
2,26623,3,3,,103217374,56208,Unspecified,,,,,Dissociation constant (pKa1),Other,7636859.0,
3,26833,3,3,,103217374,56208,Unspecified,,,,,Dissociation constant (pKa2),Other,7636859.0,
4,30551,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibition concentration in vitro determined against Acinetobacter sp CMX669,Other,3934382.0,
5,64076,7,2,,103217374,56208,Unspecified,,,,,In vitro antibacterial activity against Escherichia coli (A 15119),Other,2918499.0,
6,66387,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibition concentration in vitro determined against Enterobacteri aerogenes ATCC 13048,Other,3934382.0,
7,69490,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibitory concentration against gram-negative Escherichia coli Vogel (EC-1),Other,7636859.0,
8,70799,6,2,,103217374,56208,Unspecified,,,,,Compound was evaluated for inhibitory activity against Escherichia coli Juhl (in vivo),Other,3934382.0,
9,70800,7,2,,103217374,56208,Unspecified,,,,,Minimum inhibition concentration in vitro determined against Escherichia coli juhl,Other,3934382.0,
10,94133,7,2,,103217374,56208,Unspecified,,,,,In vitro antibacterial activity against Klebsiella pneumoniae (A 9664),Other,2918499.0,
11,95882,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibition concentration in vitro determined against Klebsiella pneumoniae 8045,Other,3934382.0,
12,112501,10,1,,103217374,56208,Unspecified,,,,,In vivio inhibitory activity against Escherichia coli Juhl after subcutaneous administration in mice,Other,3934382.0,
13,113528,6,2,,103217374,56208,Unspecified,,,,,In vivo inhibitory activity of teh compound against Escherichia coli Juhl after peroral administration in mice,Other,3934382.0,
14,143596,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibitory concentration against Mycobacterium fortuitum,Other,7636859.0,
15,143597,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibitory concentration against Mycobacterium smegmatis,Other,7636859.0,
16,151055,7,2,,103217374,56208,Unspecified,,,,,In vitro antibacterial activity against Pseudomonas aeruginosa (A 9843),Other,2918499.0,
17,163111,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibitory concentration against gram-negative Pseudomonas aeruginosa U1-18 (PA-7),Other,7636859.0,
18,163921,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibition concentration in vitro determined against Pseudomona aeruginosa 5007,Other,3934382.0,
19,163922,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibition concentration in vitro determined against Pseudomona aeruginosa K799/WT,Other,3934382.0,
20,197880,7,2,,103217374,56208,Unspecified,,,,,In vitro antibacterial activity against Staphylococcus aureus Smith (A9537),Other,2918499.0,
21,203132,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibitory concentration against gram-positive Staphylococcus aureus H-228 (SA-13),Other,7636859.0,
22,206205,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibition concentration in vitro determined against Staphylococcus epidermidis 3519,Other,3934382.0,
23,207550,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibition concentration in vitro determined against Staphylococcus aureus ATCC 6538P,Other,3934382.0,
24,207573,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibition concentration in vitro determined against Staphylococcus aureus CMX 686B,Other,3934382.0,
25,209583,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibition concentration in vitro determined against Streptococcus faecium ATCC 8043,Other,3934382.0,
26,209769,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibitory concentration against gram-positive Streptococcus pyogenes C203 (SP1-1),Other,7636859.0,
27,210401,6,2,,103217374,56208,Unspecified,,,,,Minimum inhibition concentration in vitro determined against Streptococcus pyogenes 930,Other,3934382.0,
28,278228,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21,Other,17043131.0,
29,278229,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 gyrA+,Other,17043131.0,
30,278230,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 acrAB::Kan,Other,17043131.0,
31,278231,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 tolC::Kan,Other,17043131.0,
32,278232,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 GyrA S83F mutant,Other,17043131.0,
33,278233,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 gyrA+,Other,17043131.0,
34,278234,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium GyrA S21-1 acrAB::Kan with GyrA S83F mutation,Other,17043131.0,
35,278235,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 tolC::Kan with GyrA S83F mutation,Other,17043131.0,
36,278236,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 with GyrA S83F, ParC S80I mutation",Other,17043131.0,
37,278237,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 gyrA+ with ParC S80I mutation,Other,17043131.0,
38,278238,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 acrAB::Kan with GyrA S83F, ParC S80I mutation",Other,17043131.0,
39,278239,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 tolC::Kan with GyrA S83F, ParC S80I mutation",Other,17043131.0,
40,278240,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 with GyrA S83F, ParC S80I mutation",Other,17043131.0,
41,278241,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 gyrA+ with ParC S80I mutation,Other,17043131.0,
42,278242,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 acrAB::Kan with GyrA S83F, ParC S80I mutation",Other,17043131.0,
43,278243,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 tolC::Kan with GyrA S83F, ParC S80I mutation",Other,17043131.0,
44,278244,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 with GyrA S83F, ParC S80I mutation",Other,17043131.0,
45,278245,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 gyrA+ with ParC S80I mutation,Other,17043131.0,
46,278246,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 acrAB::Kan with GyrA S83F, ParC S80I mutation",Other,17043131.0,
47,278247,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 tolC::Kan with GyrA S83F, ParC S80I mutation",Other,17043131.0,
48,278248,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
49,278249,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
50,278250,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
51,278251,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
52,278252,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
53,278253,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
54,278254,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
55,278255,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 tolC::Kan with GyrA S83F, D87N, parC S80I mutation",Other,17043131.0,
56,278256,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
57,278257,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
58,278258,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
59,278259,6,2,,103217374,56208,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
60,278260,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 with GyrA D87G mutation,Other,17043131.0,
61,278261,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 gyrA+ with GyrA D87G mutation,Other,17043131.0,
62,278262,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 acrAB::Kan with GyrA D87G mutation,Other,17043131.0,
63,278263,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 tolC::Kan with GyrA D87G mutant,Other,17043131.0,
64,278264,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 with GyrA S38F mutation,Other,17043131.0,
65,278265,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 gyrA+ with GyrA S38F mutation,Other,17043131.0,
66,278266,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 acrAB::Kan with GyrA S38F mutation,Other,17043131.0,
67,278267,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 tolC::Kan with GyrA S38F mutation,Other,17043131.0,
68,278268,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 with GyrA D87G mutation,Other,17043131.0,
69,278269,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 gyrA+ with GyrA D87G mutation,Other,17043131.0,
70,278270,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 acrAB::Kan with GyrA D87G mutation,Other,17043131.0,
71,278271,6,2,,103217374,56208,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 tolC::Kan with GyrA D87G mutation,Other,17043131.0,
72,515780,5,1,,103217374,56208,Unspecified,,,,,Intrinsic solubility of the compound in water,Other,20810286.0,
73,624349,1,2,,92309265,56208,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
74,625144,5,5,,103217374,56208,Unspecified,239977155.0,,,IC50,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),Confirmatory,,
75,625145,4,7,,103217374,56208,Unspecified,20138087.0,10800.0,,IC50,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),Confirmatory,,
76,625146,5,5,,103217374,56208,Unspecified,126397.0,100009114.0,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),Confirmatory,,
77,625147,4,7,,103217374,56208,Unspecified,395398606.0,4159.0,,IC50,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
78,625148,4,7,,103217374,56208,Unspecified,60392672.0,4160.0,,IC50,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
79,625149,4,7,,103217374,56208,Unspecified,729996.0,4161.0,,IC50,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
80,625150,5,5,,103217374,56208,Unspecified,113978.0,4128.0,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),Confirmatory,,
81,625151,4,7,,103217374,56208,Unspecified,113118.0,1128.0,,IC50,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
82,625152,4,7,,103217374,56208,Unspecified,113122.0,1129.0,,IC50,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
83,625153,4,7,,103217374,56208,Unspecified,113125.0,1131.0,,IC50,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
84,625154,4,7,,103217374,56208,Unspecified,23503039.0,1132.0,,IC50,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
85,625155,4,7,,103217374,56208,Unspecified,543761.0,1133.0,,IC50,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
86,625156,1,9,,103217374,56208,Unspecified,128997.0,4886.0,,,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),Other,,
87,625157,6,2,,103217374,56208,Unspecified,1352610.0,4887.0,,IC50,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),Confirmatory,,
88,625158,3,4,,103217374,56208,Unspecified,,,,IC50,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),Confirmatory,,
89,625159,5,5,,103217374,56208,Unspecified,266646.0,24598.0,,IC50,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",Confirmatory,,
90,625160,1,9,,103217374,56208,Unspecified,266649.0,18126.0,,,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",Other,,
91,625161,4,7,,103217374,56208,Unspecified,311033488.0,4985.0,,IC50,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",Confirmatory,,
92,625162,4,7,,103217374,56208,Unspecified,116242691.0,4986.0,,IC50,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
93,625163,4,7,,103217374,56208,Unspecified,2851402.0,4988.0,,IC50,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
94,625164,1,6,,103217374,56208,Unspecified,,,,,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),Other,,
95,625165,3,4,,103217374,56208,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
96,625166,3,4,,103217374,56208,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
97,625167,5,5,,103217374,56208,Unspecified,317373261.0,8654.0,,IC50,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),Confirmatory,,
98,625168,4,7,,103217374,56208,Unspecified,129557.0,5724.0,,IC50,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),Confirmatory,,
99,625169,1,6,,103217374,56208,Unspecified,,,,,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),Other,,
100,625170,3,4,,103217374,56208,Unspecified,,,,IC50,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),Confirmatory,,
101,625171,4,7,,103217374,56208,Unspecified,7531135.0,3757.0,,IC50,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),Confirmatory,,
102,625172,4,7,,103217374,56208,Unspecified,75071465.0,,,IC50,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),Confirmatory,,
103,625173,5,5,,103217374,56208,Unspecified,2822103.0,100009274.0,,IC50,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",Confirmatory,,
104,625174,5,5,,103217374,56208,Unspecified,266321.0,834.0,,IC50,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",Confirmatory,,
105,625175,5,5,,103217374,56208,Unspecified,115725.0,1511.0,,IC50,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",Confirmatory,,
106,625176,1,9,,103217374,56208,Unspecified,119292.0,1991.0,,,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",Other,,
107,625177,5,5,,103217374,56208,Unspecified,116852.0,4312.0,,IC50,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
108,625178,5,5,,103217374,56208,Unspecified,269849668.0,4318.0,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
109,625179,1,9,,103217374,56208,Unspecified,317373571.0,5578.0,,,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),Other,,
110,625180,5,5,,103217374,56208,Unspecified,232066.0,5595.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
111,625181,5,5,,103217374,56208,Unspecified,119554.0,5594.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
112,625182,5,5,,103217374,56208,Unspecified,2499600.0,1432.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
113,625183,5,5,,103217374,56208,Unspecified,1352673.0,5530.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",Confirmatory,,
114,625184,5,5,,103217374,56208,Unspecified,2811086.0,1956.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
115,625185,5,5,,103217374,56208,Unspecified,125370.0,2534.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
116,625186,5,5,,103217374,56208,Unspecified,119533.0,2064.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
117,625187,5,5,,103217374,56208,Unspecified,125474.0,3932.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
118,625188,1,9,,103217374,56208,Unspecified,33112650.0,5788.0,,,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",Other,,
119,625189,1,7,,103217374,56208,Unspecified,,,,,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",Other,,
120,625190,4,5,,103217374,56208,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),Confirmatory,,
121,625191,4,7,,103217374,56208,Unspecified,112815.0,25075.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
122,625192,4,7,,103217374,56208,Unspecified,543727.0,3356.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),Confirmatory,,
123,625193,5,5,,103217374,56208,Unspecified,113037.0,43.0,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Confirmatory,,
124,625194,4,7,,103217374,56208,Unspecified,231473.0,134.0,,IC50,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),Confirmatory,,
125,625195,4,7,,103217374,56208,Unspecified,543740.0,135.0,,IC50,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),Confirmatory,,
126,625196,5,6,,103217374,56208,Unspecified,803374855.0,140.0,,IC50,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),Confirmatory,,
127,625197,3,4,,103217374,56208,Unspecified,,,,IC50,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),Confirmatory,,
128,625198,4,7,,103217374,56208,Unspecified,1168247.0,29412.0,,IC50,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
129,625199,4,7,,103217374,56208,Unspecified,543734.0,24173.0,,IC50,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
130,625200,4,7,,103217374,56208,Unspecified,1168243.0,146.0,,IC50,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
131,625201,4,7,,103217374,56208,Unspecified,1351829.0,150.0,,IC50,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Confirmatory,,
132,625202,4,7,,103217374,56208,Unspecified,613504690.0,151.0,,IC50,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),Confirmatory,,
133,625203,4,7,,103217374,56208,Unspecified,20141211.0,152.0,,IC50,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),Confirmatory,,
134,625204,4,7,,103217374,56208,Unspecified,48429211.0,153.0,,IC50,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
135,625205,4,7,,103217374,56208,Unspecified,296439450.0,154.0,,IC50,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),Confirmatory,,
136,625206,4,7,,103217374,56208,Unspecified,461604.0,155.0,,IC50,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
137,625207,4,7,,103217374,56208,Unspecified,128616.0,6530.0,,IC50,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
138,625208,5,5,,103217374,56208,Unspecified,1168407.0,24192.0,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),Confirmatory,,
139,625209,4,7,,103217374,56208,Unspecified,1703214.0,186.0,,IC50,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),Confirmatory,,
140,625210,3,4,,103217374,56208,Unspecified,,,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",Confirmatory,,
141,625211,1,6,,103217374,56208,Unspecified,,,,,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),Other,,
142,625212,3,4,,103217374,56208,Unspecified,,,,IC50,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),Confirmatory,,
143,625213,4,7,,103217374,56208,Unspecified,2506481.0,624.0,,IC50,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),Confirmatory,,
144,625214,1,9,,103217374,56208,Unspecified,550544247.0,799.0,,,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),Other,,
145,625215,3,4,,103217374,56208,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",Confirmatory,,
146,625216,3,4,,103217374,56208,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",Confirmatory,,
147,625217,4,7,,103217374,56208,Unspecified,1168220.0,3357.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
148,625218,4,7,,103217374,56208,Unspecified,112816.0,3358.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),Confirmatory,,
149,625219,3,4,,103217374,56208,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),Confirmatory,,
150,625220,4,7,,103217374,56208,Unspecified,6224984.0,100135548.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),Confirmatory,,
151,625221,4,7,,103217374,56208,Unspecified,1703010.0,3362.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
152,625222,4,7,,103217374,56208,Unspecified,400630.0,6532.0,,IC50,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",Confirmatory,,
153,625223,4,7,,103217374,56208,Unspecified,74752153.0,10280.0,,IC50,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),Confirmatory,,
154,625224,3,4,,103217374,56208,Unspecified,,,,IC50,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),Confirmatory,,
155,625225,3,4,,103217374,56208,Unspecified,,,,IC50,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",Confirmatory,,
156,625226,4,7,,103217374,56208,Unspecified,128359.0,6869.0,,IC50,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),Confirmatory,,
157,625227,4,7,,103217374,56208,Unspecified,229462950.0,6865.0,,IC50,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),Confirmatory,,
158,625228,4,7,,103217374,56208,Unspecified,113832.0,24208.0,,IC50,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),Confirmatory,,
159,625229,5,5,,103217374,56208,Unspecified,254763392.0,6916.0,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),Confirmatory,,
160,625230,1,6,,103217374,56208,Unspecified,,,,,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",Other,,
161,625231,4,7,,103217374,56208,Unspecified,143811474.0,2321.0,,IC50,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),Confirmatory,,
162,625232,1,9,,103217374,56208,Unspecified,418253.0,7433.0,,,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),Other,,
163,625233,4,7,,103217374,56208,Unspecified,586197.0,552.0,,IC50,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),Confirmatory,,
164,625234,3,4,,103217374,56208,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",Confirmatory,,
165,625235,4,7,,103217374,56208,Unspecified,115562.0,1268.0,,IC50,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),Confirmatory,,
166,625236,5,5,,103217374,56208,Unspecified,115456.0,760.0,,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),Confirmatory,,
167,625237,4,7,,103217374,56208,Unspecified,1168965.0,729230.0,,IC50,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),Confirmatory,,
168,625238,4,7,,103217374,56208,Unspecified,1705894.0,1233.0,,IC50,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),Confirmatory,,
169,625239,4,7,,103217374,56208,Unspecified,1705896.0,1234.0,,IC50,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),Confirmatory,,
170,625240,1,9,,103217374,56208,Unspecified,108936015.0,3577.0,,,DRUGMATRIX: Chemokine CXCR1 (IL-8A),Other,,
171,625241,4,7,,103217374,56208,Unspecified,1352454.0,3579.0,,IC50,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),Confirmatory,,
172,625242,4,7,,103217374,56208,Unspecified,416772.0,886.0,,IC50,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",Confirmatory,,
173,625243,5,5,,103217374,56208,Unspecified,317373262.0,5742.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
174,625244,5,5,,103217374,56208,Unspecified,3915797.0,5743.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
175,625245,5,5,,103217374,56208,Unspecified,117144.0,1544.0,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
176,625246,1,9,,103217374,56208,Unspecified,308153612.0,1548.0,,,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Other,,
177,625247,5,5,,103217374,56208,Unspecified,60416369.0,1557.0,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
178,625248,5,5,,103217374,56208,Unspecified,6686268.0,1559.0,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
179,625249,5,5,,103217374,56208,Unspecified,84028191.0,1565.0,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
180,625250,5,5,,103217374,56208,Unspecified,117250.0,1571.0,,IC50,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
181,625251,5,5,,103217374,56208,Unspecified,116241312.0,1576.0,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",Confirmatory,,
182,625252,4,7,,103217374,56208,Unspecified,118228.0,1812.0,,IC50,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),Confirmatory,,
183,625253,4,7,,103217374,56208,Unspecified,118206.0,1813.0,,IC50,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
184,625254,4,7,,103217374,56208,Unspecified,1169206.0,1814.0,,IC50,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
185,625255,4,7,,103217374,56208,Unspecified,1345939.0,1815.0,,IC50,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
186,625256,4,7,,103217374,56208,Unspecified,266667.0,6531.0,,IC50,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
187,625257,4,7,,103217374,56208,Unspecified,119606.0,1909.0,,IC50,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),Confirmatory,,
188,625258,4,7,,103217374,56208,Unspecified,544257.0,2099.0,,IC50,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
189,625259,4,7,,103217374,56208,Unspecified,6166154.0,2100.0,,IC50,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
190,625260,3,4,,103217374,56208,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",Confirmatory,,
191,625261,3,4,,103217374,56208,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",Confirmatory,,
192,625262,3,4,,103217374,56208,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",Confirmatory,,
193,625263,4,7,,103217374,56208,Unspecified,121069.0,2908.0,,IC50,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),Confirmatory,,
194,625264,3,4,,103217374,56208,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",Confirmatory,,
195,625265,1,6,,103217374,56208,Unspecified,,,,,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",Other,,
196,625266,3,4,,103217374,56208,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",Confirmatory,,
197,625267,3,4,,103217374,56208,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",Confirmatory,,
198,625268,4,2,,103217374,56208,Unspecified,121579.0,24397.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
199,625268,4,2,,103217374,56208,Unspecified,121580.0,114516.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
200,625268,4,2,,103217374,56208,Unspecified,121604.0,25456.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
201,625268,4,2,,103217374,56208,Unspecified,12230887.0,25674.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
202,625269,4,7,,103217374,56208,Unspecified,547645.0,3269.0,,IC50,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",Confirmatory,,
203,625270,4,7,,103217374,56208,Unspecified,123120.0,3274.0,,IC50,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),Confirmatory,,
204,625271,5,5,,103217374,56208,Unspecified,123343.0,3156.0,,IC50,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),Confirmatory,,
205,625272,3,4,,103217374,56208,Unspecified,,,,IC50,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",Confirmatory,,
206,625273,4,6,,103217374,56208,Unspecified,124531.0,24954.0,,IC50,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),Confirmatory,,
207,625274,1,6,,103217374,56208,Unspecified,,,,,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),Other,,
208,625275,3,4,,103217374,56208,Unspecified,,,,IC50,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",Confirmatory,,
209,651828,1,2,,92309265,56208,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
210,720641,1,2,,92309265,56208,Active,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
211,720717,1,3,,92309265,56208,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
212,743344,1,1,,174006988,56208,Inactive,,,8.4071,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
213,743345,1,1,,174006988,56208,Inactive,,,11.8754,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
214,743346,1,1,,174006988,56208,Inactive,,,6.678,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
215,743347,1,1,,174006988,56208,Inactive,,,16.7744,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
216,1126744,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against Salmonella assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
217,1126745,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
218,1126746,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
219,1126747,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against Escherichia coli assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
220,1126748,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against duck Escherichia coli assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
221,1126749,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against Salmonella assessed as zone of inhibition at 2 ug/ml,Other,24684842.0,
222,1126750,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa assessed as zone of inhibition at 2 ug/ml,Other,24684842.0,
223,1126751,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus assessed as zone of inhibition at 2 ug/ml,Other,24684842.0,
224,1126752,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against Escherichia coli assessed as zone of inhibition at 2 ug/ml,Other,24684842.0,
225,1126753,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against duck Escherichia coli assessed as zone of inhibition at 2 ug/ml,Other,24684842.0,
226,1126754,1,1,,103217374,56208,Active,,,,,Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
227,1126755,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 741 assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
228,1126756,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 753 assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
229,1126757,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 758 assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
230,1126758,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 760 assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
231,1126759,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 821 assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
232,1126760,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 930 assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
233,1126761,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1237 assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
234,1126762,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1256 assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
235,1126763,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1259 assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
236,1126764,1,1,,103217374,56208,Unspecified,,,,,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1288 assessed as growth inhibition after 7 days by microtiter plate assay,Other,24684842.0,
237,1159520,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
238,1159521,1,1,,251919829,56208,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
239,1159523,1,1,,251919829,56208,Inconclusive,15928672.0,19885.0,23.7101,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
240,1159525,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
241,1159526,1,1,,251919829,56208,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
242,1159527,1,1,,251919829,56208,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
243,1159528,1,1,,251919829,56208,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
244,1159529,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
245,1159531,1,1,,251919829,56208,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
246,1159551,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
247,1159552,1,1,,251919829,56208,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
248,1159555,1,1,,251919829,56208,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
249,1159580,2,1,,268735083,56208,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
250,1224824,1,1,,174006988,56208,Inactive,,,4.1763,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
251,1224825,1,1,,174006988,56208,Inactive,,,16.6261,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
252,1224834,3,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
253,1224835,1,1,,251919829,56208,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
254,1224836,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
255,1224837,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
256,1224838,1,1,,251919829,56208,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
257,1224839,1,1,,251919829,56208,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
258,1224840,3,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
259,1224841,3,1,,251919829,56208,Inactive,325495545.0,2101.0,10.5909,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
260,1224842,3,1,,251919829,56208,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
261,1224843,1,1,,251919829,56208,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
262,1224844,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
263,1224845,1,1,,251919829,56208,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
264,1224846,1,1,,251919829,56208,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
265,1224847,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
266,1224848,3,1,,251919829,56208,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
267,1224849,3,1,,251919829,56208,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
268,1224857,2,1,,174006988,56208,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
269,1224859,2,1,,174006988,56208,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
270,1224863,1,1,,176484464,56208,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
271,1224863,1,1,,316919043,56208,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
272,1224867,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
273,1224868,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
274,1224869,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
275,1224870,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
276,1224871,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
277,1224872,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
278,1224873,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
279,1224874,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
280,1224875,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
281,1224876,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
282,1224877,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
283,1224878,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
284,1224879,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
285,1224880,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
286,1224881,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
287,1224882,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
288,1224883,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
289,1224884,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
290,1224885,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
291,1224886,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
292,1224887,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
293,1224888,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
294,1224889,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
295,1224890,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
296,1224892,1,1,,251919829,56208,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
297,1224893,1,1,,251919829,56208,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
298,1224894,1,1,,251919829,56208,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
299,1224895,1,1,,251919829,56208,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
300,1224896,1,1,,251919829,56208,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
301,1224905,2,1,,92309265,56208,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
302,1224905,2,1,,92309265,56208,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
303,1259241,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
304,1259242,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
305,1259243,1,1,,251919829,56208,Inactive,124375976.0,367.0,21.1317,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
306,1259244,1,1,,251919829,56208,Inconclusive,348019627.0,2099.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
307,1259247,1,1,,251919829,56208,Inconclusive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
308,1259248,1,1,,251919829,56208,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
309,1259252,1,1,,174006988,56208,Inconclusive,169655958.0,,16.6261,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
310,1259253,1,1,,174006988,56208,Inconclusive,169655958.0,,7.4266,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
311,1259255,1,1,,174006988,56208,Inconclusive,169655958.0,,16.6261,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
312,1259256,1,1,,174006988,56208,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
313,1259310,1,1,,333494270,56208,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
314,1259364,1,1,,251919829,56208,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
315,1259365,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
316,1259366,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
317,1259367,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
318,1259368,1,1,,251919829,56208,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
319,1259369,1,1,,251919829,56208,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
320,1259377,1,1,,251919829,56208,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
321,1259378,1,1,,251919829,56208,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
322,1259379,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
323,1259380,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
324,1259381,1,1,,251919829,56208,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
325,1259382,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
326,1259383,1,1,,251919829,56208,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
327,1259384,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
328,1259385,1,1,,251919829,56208,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
329,1259386,1,1,,251919829,56208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
330,1259387,1,1,,251919829,56208,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
331,1259388,1,1,,251919829,56208,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
332,1259390,1,1,,251919829,56208,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
333,1259391,1,1,,251919829,56208,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
334,1259392,1,1,,251919829,56208,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
335,1259393,1,1,,251919829,56208,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
336,1259394,1,1,,251919829,56208,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
337,1259395,1,1,,251919829,56208,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
338,1259396,1,1,,251919829,56208,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
339,1259401,1,1,,251919829,56208,Inconclusive,325495545.0,2101.0,17.7801,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
340,1259402,1,1,,251919829,56208,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
341,1259403,1,1,,251919829,56208,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
342,1259404,1,1,,251919829,56208,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
343,1259407,1,1,,363906450,56208,Inactive,,,,,CCRIS mutagenicity studies,Other,,
344,1259416,1,2,,340083046,56208,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
345,1259416,1,2,,375172019,56208,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
346,1259421,1,1,,340083046,56208,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
347,1259421,1,1,,375172019,56208,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
348,1259423,1,2,,354988163,56208,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
